Nanotechnology News and Research

RSS

New lab-on-a-chip system can detect effects of toxic substances on hemoglobin in blood

A new lab-on-a-chip system, developed by the University of Twente in The Netherlands, is capable of fast analysis of the effects of toxic substances on hemoglobin, for example. It mimicks human metabolism.

4 Oct 2016

Researchers reveal how ultrasmall nanoparticles can kill cancer cells

Nanoparticles known as Cornell dots, or C dots, have shown great promise as a therapeutic tool in the detection and treatment of cancer.

29 Sep 2016

New research shows nanoscale device could be 'missing link' in development of neuroprosthetics

New research, led by the University of Southampton, has demonstrated that a nanoscale device, called a memristor, could be the 'missing link' in the development of implants that use electrical signals from the brain to help treat medical conditions.

27 Sep 2016

EVG brings high-volume manufacturing process solutions to biotechnology and medical device market

EV Group, a leading supplier of wafer bonding and lithography equipment for the MEMS, nanotechnology and semiconductor markets, today announced that it is increasing its focus on bringing its high-volume manufacturing process solutions and services to the biotechnology and medical device market.

27 Sep 2016

Magnetic bacteria can be promising vehicle for efficiently delivering tumor-fighting drugs

Researchers funded in part by the National Institute of Biomedical Imaging and Bioengineering have recently shown that magnetic bacteria are a promising vehicle for more efficiently delivering tumor-fighting drugs. They reported their results in the August 2016 issue of Nature Nanotechnology.

23 Sep 2016

Rensselaer awarded $2.2 million grant to develop ion conductive alkaline membrane materials

Rensselaer Polytechnic Institute has been awarded $2.2 million in funding from the U.S. Department of Energy's Advanced Research Projects Agency-Energy to develop innovative ion conduction materials for next-generation renewable energy conversion and storage technology.

19 Sep 2016

Nanoparticles shaped like rods and worms could effectively deliver drugs, research suggests

When it comes to delivering drugs, nanoparticles shaped like rods and worms are the best bet for making the daunting journey to the centre of a cell, new Australian research suggests.

13 Sep 2016

Nanomechanical microcantilevers can quickly detect mutations in patients with malignant melanoma

Changes in the genetic make-up of tissue samples can be detected quickly and easily using a new method based on nanotechnology.

6 Sep 2016

Nanopores can be effective way to measure DNA interactions with emerging anti-cancer drugs

Cancer thrives when mutated cells undergo frequent division. Most anti-cancer drugs work by inserting themselves in between the DNA base pairs that encode our genetic information.

1 Sep 2016

Solution made of silver nanoparticles shows promise in healing diabetic foot ulcers

One of the major complications of diabetes is the appearance of wounds in the lower extremities that do not heal properly.

31 Aug 2016

New UCF technology for destroying metastatic breast cancer cells licensed for clinical trials

A University of Central Florida cancer researcher has discovered a way to kill spreading breast cancer cells and her new technology has generated a licensing agreement that will accelerate the therapy's path to clinical trials.

25 Aug 2016

Researchers investigate link between diet, obesity-linked Type 2 diabetes, and spinal disc degeneration

Can a diet high in processed fat and sugar and Type 2 diabetes cause degeneration of intervertebral discs in the spine? If so, what is happening, and can it be prevented? As part of an ongoing collaboration between Rensselaer Polytechnic Institute and the Icahn School of Medicine at Mount Sinai - a partnership that draws upon the expertise of both schools to address significant health problems - researchers hope to answer those questions by investigating the link between diet, obesity-linked Type 2 diabetes, and intervertebral disc degeneration.

23 Aug 2016

Ginger-derived nanoparticles may be good medicine for inflammatory bowel disease

A recent study by researchers at the Atlanta Veterans Affairs Medical Center took them to a not-so-likely destination: local farmers markets. They went in search of fresh ginger root.

18 Aug 2016

Researchers develop new nanorobotic agents to deliver drugs by targeting cancerous tumours

Researchers from Polytechnique Montréal, Université de Montréal and McGill University have just achieved a spectacular breakthrough in cancer research.

16 Aug 2016

Could nanotechnology turn the cancer cell suicide switch back on? An interview with Professor Dipanjan Pan

Before I explain the discovery, I would take a step back and explain an interesting event that takes place in the cancer cells. Normal cells follow a rapid and irreversible process to efficiently eradicate dysfunctional cells. This is a natural process by which damaged cells commit ‘suicide’. This process is known as apoptosis or programmed cell death.

15 Aug 2016

Research finding opens new avenues to tailor drug development with Upsalite

For the first time, researchers have revealed the nanostructure of the mesoporous magnesium carbonate Upsalite and pore size control was achieved without organic templates or swelling agents.

11 Aug 2016

New carbon nanomaterial pot several times deeper than any similar nanostructure

A novel, pot-shaped, carbon nanomaterial developed by researchers from Kumamoto University, Japan is several times deeper than any hollow carbon nanostructure previously produced.

5 Aug 2016

NJIT receives two-year funding to develop ways to protect ecosystems and communities from flood waters

The Center for Resilient Design at New Jersey Institute of Technology, part of the university's College of Architecture and Design, has received a two-year grant from the New Jersey Sea Grant Consortium to develop ways to protect ecosystems and their surrounding communities from flood waters.

3 Aug 2016

Preclinical data on Selecta’s novel immune tolerance platform published in Nature Nanotechnology

Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company developing targeted antigen-specific immune therapies for rare and serious diseases, announced today that Nature Nanotechnology has published an article that presents preclinical results from Selecta’s research which demonstrate the broad potential applicability of Selecta’s novel immune tolerance platform.

2 Aug 2016

Waterloo researchers unveil new screening tool and data at 2016 AAIC

Two studies involving University of Waterloo researchers presented this week at the 2016 Alzheimer's Association International Conference (AAIC) in Toronto highlight a new diagnostic tool that can identify Alzheimer's disease long before the onset of symptoms as well as the increasing prevalence of Alzheimer's disease in Ontario.

27 Jul 2016